Navigation Links
Eurocine Vaccines Strengthens the Organization for Further Development
Date:4/7/2017

STOCKHOLM, April 7, 2017 /PRNewswire/ -- Eurocine Vaccines strengthens the organization with necessary competence, not only to prepare for further development of its first product, the nasal influenza vaccine candidate Immunose™ FLU, but also for further development of a pipeline of other vaccines based on the patented technology platform Endocine™.

"In parallel with finalizing the analyses and evaluation of the current study, we now prepare for the next steps of development. Reinforcing the organization with Sandra Jeldes Granstrand, a senior and experienced Project Leader of CMC[1], supports our ambitious strategy and rapid development ahead", said CSO Anna-Karin Maltais.

Simultaneously, CSO Anna-Karin Maltais is appointed Vice President Research and Development.

"This emphasizes our positive ambitions as we continue building value", said CEO Hans Arwidsson and continued "Ensuring that the next influenza season can be well used for further development, opens for a shorter way to market, to the benefit of patients and partners."

Results from the ongoing clinical study are expected in June/July 2017.

More information about the study can be found at www.clinicaltrials.gov.

[1] Chemistry Manufacturing and Control

CONTACT:
CEO of Eurocine Vaccines AB
hans.arwidsson@eurocine-vaccines.com  
+46-70-634-0171

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/eurocine-vaccines/r/eurocine-vaccines-strengthens-the-organization-for-further-development,c2235009

The following files are available for download:

http://mb.cision.com/Main/11552/2235009/654837.pdf

Se news release

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eurocine-vaccines-strengthens-the-organization-for-further-development-300436536.html


'/>"/>
SOURCE Eurocine Vaccines
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Animal Vaccines Market Expected to Reach $9,159 Million by 2022 - Allied Market Research
2. New Access to Vaccines Index Reveals First Landscape of Vaccine Company Actions to Improve Immunisation Coverage
3. Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025
4. Global Influenza Vaccines - World Industry Market Outlook 2017-2027
5. Research and Markets - Global Travel Vaccines Market 2016-2020: Market Growth at CAGR of 6.83% - Growing Demand Among Travelers / Additional Age Group Approval / Inclusion in NIP
6. Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
7. Global Influenza Vaccines Market and Forecast to 2021: North America Accounted for 50% of the $5 Billion Market in 2015 - Research and Markets
8. Research and Markets - Global H1N1 Vaccines Market Analysis 2016-2025 - Trends, Technologies & Opportunities Report 2016-2025 - Vendors: Novartis, Zydus Cadila, Merck
9. Vaccines a 28 Billion-Dollar Market, Kalorama Information Study Finds
10. Kalorama: After Allergan Merger Halt, Vaccines a Focus for Pfizer
11. Profectus and Vyriad Form Global Collaboration to Develop Oncolytic Recombinant VSV (rVSV) Vaccines for Cancer Immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:7/31/2017)... , July 31, 2017 Three Tru-D SmartUVC robots ... South Korea . Tru-D, short for "Total Room Ultraviolet Disinfection," ... rooms after an environmental services (ES) professional cleans the area with traditional ... Tru-D ... "Although the BAACH has ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
Breaking Medicine Technology:
(Date:8/16/2017)... NJ (PRWEB) , ... August 16, 2017 , ... ... is offering an opportunity for men and women to train as hospice ... families dealing with life-limiting illness. For over 30 years, the agency has trained ...
(Date:8/16/2017)... ... August 16, 2017 , ... First Choice Emergency Room , the ... J. Harrison, as the new Medical Director of its Sienna Plantation facility. , ... of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, Area Medical Director of ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... West Orange, NJ (PRWEB) , ... August 16, 2017 , ... With low back pain ... not even know what causes its kissing cousin – upper back pain. But this equally ... bevy of treatment options, according to Kaixuan Liu, MD, PhD , founder and president ...
(Date:8/16/2017)... ... 2017 , ... “Faith, Through The Eyes of A Child” is the creation of published author, ... looking down at her. Since she was in such great pain, my mother thought that ... everything went well. It wasn’t until I was about eight years old, when I had ...
Breaking Medicine News(10 mins):